Join us virtually on November 10th at 1pm PST for an update on the HEALEY ALS Platform Trial with Dr. Sabrina Paganoni.

We'll cover:

• The status of current trial drug regimens.

• What treatment regimens are currently enrolling.

• Who qualifies for the drug treatments currently enrolling.

• The outlook for additional treatments to be added in the future.

• + an open Q&A session

Speaker & Moderator:

Dr. Sabrina Paganoni is the Co-Principal Investigator of the HEALEY ALS Platform Trial, Co-Director of the Neurological Clinical Research Institue, Mass General Hospital, and an Assistant Professor at Harvard Medical School/Spaulding Rehabilitation Hospital

Taner Dagdelen is the CEO & Co-Founder of Unite Genomics.